Psychiatry · Morris, IL
NPI
1346289980
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1401 Lakewood Dr, Sutie A
Morris, IL, 60450
Phone (815) 942-6323
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
485 services
Medicare patients, 2024
173
Average age 64
Drug cost, 2024
$499K
5,725 prescriptions
Company payments, 2025
$736
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rifki J Goldin Mertdogan was code 99213 (office e&m - established), 193 times for 92 patients. In total Rifki J Goldin Mertdogan billed 485 services in 15 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 193 | 92 | $60.64 | $12K |
| 99442 Telephone Services | Office | 103 | 62 | $59.46 | $6,124 |
| 99214 Office E&M - Established | Office | 84 | 49 | $84.12 | $7,066 |
| 99443 Telephone Services | Office | 65 | 46 | $89.46 | $5,815 |
| 90792 Psychotherapy - Nongroup | Office | 25 | 25 | $125.39 | $3,135 |
By year: 2022 $36K for 445 services; 2023 $33K for 457 services; 2024 $34K for 485 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rifki J Goldin Mertdogan prescribed most often to Medicare patients was Alprazolam, with 495 prescriptions and refills. In total Rifki J Goldin Mertdogan wrote 5,725 Medicare prescriptions that cost $499K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 495 | 541 | 65 | $3,038 |
| Clonazepam Generic | 440 | 477 | 62 | $3,432 |
| Lorazepam Generic | 389 | 442 | 50 | $2,862 |
| Trazodone Hcl Generic | 221 | 455 | 52 | $2,926 |
| Diazepam Generic | 183 | 184 | 22 | $960 |
| Quetiapine Fumarate Generic | 181 | 354 | 34 | $5,464 |
| Aripiprazole Generic | 179 | 262 | 28 | $14K |
| Fluoxetine Hcl Generic | 178 | 350 | 27 | $1,612 |
| Bupropion Xl Bupropion Hcl | 168 | 306 | 36 | $3,925 |
| Lamotrigine Generic | 157 | 277 | 30 | $1,298 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 153 | 265 | 27 | $1,988 |
| Duloxetine Hcl Generic | 147 | 284 | 30 | $2,064 |
| Zolpidem Tartrate Generic | 145 | 149 | 16 | $519 |
| Escitalopram Oxalate Generic | 138 | 288 | 30 | $1,578 |
| Olanzapine Generic | 129 | 204 | 20 | $2,072 |
Brand drugs: 285 claims; generic drugs: 5,440 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rifki J Goldin Mertdogan $736 ($736 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $437.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $437 |
| Collegium Pharmaceutical, Inc. COLL | 4 | $64.49 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $56.78 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $38.59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $35.21 |
| Almatica Pharma LLC | 2 | $27.85 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $25.67 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $17.73 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $17.72 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $15.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.